About Mireca Medicines
Mireca is a preclinical stage start-up company based in Tübingen (Germany) aiming to develop its cyclic guanosine monophosphate (cGMP) analogues for diseases with pathways showing a dysregulation of cGMP signaling, affecting the protein kinase G (PKG) pathway.
Advertisement
